226 related articles for article (PubMed ID: 8883264)
1. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
[TBL] [Abstract][Full Text] [Related]
2. Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis.
Zheng YN; Yu HJ; Hou JX; Lu CF; Zhou J
Chin Med J (Engl); 2009 Jul; 122(14):1674-80. PubMed ID: 19719970
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation.
Helley D; Girot R; Guillin MC; Bezeaud A
Br J Haematol; 1997 Nov; 99(2):268-72. PubMed ID: 9375737
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Ca(2+)-containing vesicles in sickle cell disorders.
Westerman MP; Puchulu E; Schlegel RA; Salameh M; Williamson P
J Lab Clin Med; 1994 Sep; 124(3):416-20. PubMed ID: 8083584
[TBL] [Abstract][Full Text] [Related]
5. Increased procoagulant activity of red blood cells in the presence of cisplatin.
Lü CF; Yu HJ; Hou JX; Zhou J
Chin Med J (Engl); 2008 Sep; 121(18):1775-80. PubMed ID: 19080356
[TBL] [Abstract][Full Text] [Related]
6. Biophysical characterization of beta-thalassemic red blood cells.
Desouky OS; Selim NS; El-Bakrawy EM; El-Marakby SM
Cell Biochem Biophys; 2009; 55(1):45-53. PubMed ID: 19585085
[TBL] [Abstract][Full Text] [Related]
7. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
[TBL] [Abstract][Full Text] [Related]
9. Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia.
Bunyaratvej A; Fucharoen S; Butthep P; Sae-ung N; Kamchonwongpaisan S; Khuhapinant A
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():257-60. PubMed ID: 8629118
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
11. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
Morris CL; Gruppo RA; Shukla R; Rucknagel DL
J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
[TBL] [Abstract][Full Text] [Related]
13. Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C.
Bezeaud A; Venisse L; Helley D; Trichet C; Girot R; Guillin MC
Br J Haematol; 2002 May; 117(2):409-13. PubMed ID: 11972526
[TBL] [Abstract][Full Text] [Related]
14. Altered sialic acid contents of red blood cell membrane preparations in homozygous beta-thalassemia.
Calatroni A; Barberi I; Salpietro C
Ital J Biochem; 1978; 27(2):94-103. PubMed ID: 730497
[TBL] [Abstract][Full Text] [Related]
15. Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells.
Butthep P; Wanram S; Pattanapanyasat K; Vattanaviboon P; Fucharoen S; Wilairat P
Cytometry B Clin Cytom; 2006 Nov; 70(6):432-42. PubMed ID: 16977636
[TBL] [Abstract][Full Text] [Related]
16. A rat model for sickle cell-mediated vaso-occlusion in retina.
Lutty GA; Phelan A; McLeod DS; Fabry ME; Nagel RL
Microvasc Res; 1996 Nov; 52(3):270-80. PubMed ID: 8954868
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Kean LS; Brown LE; Nichols JW; Mohandas N; Archer DR; Hsu LL
Exp Hematol; 2002 May; 30(5):394-402. PubMed ID: 12031645
[TBL] [Abstract][Full Text] [Related]
18. Density distribution of red cells and prognostic significance in 50 patients with homozygous sickle-cell disease.
Pajot N; Maier-Redelsperger M; Dode C; Labie D; Girot R
Haematologia (Budap); 1988; 21(4):189-97. PubMed ID: 3209123
[TBL] [Abstract][Full Text] [Related]
19. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
20. Changes of hemostatic factors in patients with hemoglobinopathies.
Oner AF; Gürgey A; Okur H; Kirazli S; Gümrük F; Altay C
Turk J Pediatr; 1999; 41(3):323-7. PubMed ID: 10770092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
